H Pylori
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 7, 2007; 13(21): 2923-2931
Published online Jun 7, 2007. doi: 10.3748/wjg.v13.i21.2923
Table 4 Plasma cytokine contents in patients with CagA- H pylori infection (mean ± SE, pg/mL)
Pathological diagnosisIFN-γIL-4IL-12IL-10IL-6IL-2
Normal mucosa (NM, n = 11)
29.28 ± 0.54
11.07 ± 0.89
82.17 ± 4.59
67.29 ± 3.26
48.37 ± 4.01
54.11 ± 2.87
Chronic gastritis (CG, n = 62)
29.19 ± 1.18
10.89 ± 0.27
64.59 ± 3.10
80.25 ± 1.87
57.99 ± 2.61
53.14 ± 1.25
Gastric atrophy (GA, n = 16)
30.25 ± 2.01
10.67 ± 0.67
49.67 ± 3.28
91.28 ± 3.19
92.56 ± 5.79
42.33 ± 2.32
Intestinal metaplasia (IM, n = 15)
28.91 ± 2.23
11.08 ± 0.74
48.19 ± 2.99
98.11 ± 4.08
98.20 ± 5.92
40.98 ± 2.38
Dysplasia (DP, n = 8)
31.08 ± 2.19
11.01 ± 1.27
42.64 ± 5.49
157.09 ± 6.81
147.65 ± 6.89
34.79 ± 3.05
Gastric cancer (GC, n = 11)28.06 ± 2.4512.07 ± 0.9138.97 ± 3.29185.29 ± 9.38154.68 ± 6.7830.29 ± 2.11